Skip to content

Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary Angiography

Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary Angiography: A randomized controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190911044744N4
Enrollment
60
Registered
2023-12-11
Start date
2023-12-11
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast induced nephropathy in following coronary angiography. Nephrotic syndrome

Interventions

Intervention 1: Intervention group: recipients of curcuma tablets from Dineh company receive tablet orally 12 hours before coronary angiography to reduce nephrotoxicity of the contrast material and co

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years and older Hospitalized in Afshar Yazd Hospital, who is undergoing coronary angioplasty as a non-emergency. not receiving nephrotoxic drugs. not taking curcumin containing drugs in the past one month and no history of allergic reaction after taking oral curcumin Hospitalization in the cardiac intensive care unit for 2 days Informed consent of the patient himself or his legal guar Informed consent of the patient himself or his legal guardian.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Allergy to curcumin Receiving nephrotoxic drugs

Design outcomes

Primary

MeasureTime frame
Contrast -induced nephropathy in coronary angiography. Timepoint: 0-48 hours after surgery. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Mirzaei

Yazd University of Medical Sciences

Ehsan.Mirzaei.1369@gmail.com+98 35 3820 3419

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026